Bangkok Lab And Cosmetic PCL (BKK:BLC)
Thailand
· Delayed Price · Currency is THB 3.920
+0.020 (0.51%)
At close: Mar 6, 2026
BKK:BLC Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Operating Revenue | 1,667 | 1,557 | 1,406 | 1,238 | 1,087 | Upgrade
|
| Other Revenue | 11.11 | 21.94 | 10.99 | 3.48 | 7.94 | Upgrade
|
| Revenue | 1,679 | 1,579 | 1,417 | 1,242 | 1,095 | Upgrade
|
| Revenue Growth (YoY) | 6.31% | 11.42% | 14.11% | 13.38% | -1.03% | Upgrade
|
| Cost of Revenue | 690.23 | 684.85 | 615.07 | 537.54 | 524.74 | Upgrade
|
| Gross Profit | 988.37 | 894.14 | 802.1 | 704.43 | 570.65 | Upgrade
|
| Selling, General & Admin | 759.54 | 663.61 | 601.87 | 531.57 | 481.7 | Upgrade
|
| Operating Expenses | 759.54 | 663.61 | 601.87 | 531.57 | 481.7 | Upgrade
|
| Operating Income | 228.83 | 230.53 | 200.23 | 172.87 | 88.94 | Upgrade
|
| Interest Expense | -7.26 | -12.38 | -25.76 | -28.34 | -28.4 | Upgrade
|
| EBT Excluding Unusual Items | 221.57 | 218.15 | 174.48 | 144.53 | 60.54 | Upgrade
|
| Pretax Income | 221.57 | 218.15 | 174.48 | 144.53 | 60.54 | Upgrade
|
| Income Tax Expense | 45.32 | 42.06 | 23.65 | 14.85 | 9.41 | Upgrade
|
| Earnings From Continuing Operations | 176.25 | 176.08 | 150.82 | 129.68 | 51.13 | Upgrade
|
| Minority Interest in Earnings | -3.23 | -4.73 | -5.43 | -3.96 | 0.48 | Upgrade
|
| Net Income | 173.02 | 171.35 | 145.39 | 125.72 | 51.61 | Upgrade
|
| Net Income to Common | 173.02 | 171.35 | 145.39 | 125.72 | 51.61 | Upgrade
|
| Net Income Growth | 0.97% | 17.85% | 15.65% | 143.60% | 236.25% | Upgrade
|
| Shares Outstanding (Basic) | 597 | 591 | 544 | 447 | 364 | Upgrade
|
| Shares Outstanding (Diluted) | 597 | 591 | 544 | 447 | 364 | Upgrade
|
| Shares Change (YoY) | 0.97% | 8.53% | 21.77% | 23.00% | 34.13% | Upgrade
|
| EPS (Basic) | 0.29 | 0.29 | 0.27 | 0.28 | 0.14 | Upgrade
|
| EPS (Diluted) | 0.29 | 0.29 | 0.27 | 0.28 | 0.14 | Upgrade
|
| EPS Growth | - | 8.59% | -5.02% | 98.04% | 219.06% | Upgrade
|
| Free Cash Flow | -539.6 | 38.67 | 70.26 | 121.57 | 110.9 | Upgrade
|
| Free Cash Flow Per Share | -0.90 | 0.07 | 0.13 | 0.27 | 0.30 | Upgrade
|
| Dividend Per Share | 0.250 | 0.150 | 0.100 | - | - | Upgrade
|
| Dividend Growth | 66.67% | 50.00% | - | - | - | Upgrade
|
| Gross Margin | 58.88% | 56.63% | 56.60% | 56.72% | 52.09% | Upgrade
|
| Operating Margin | 13.63% | 14.60% | 14.13% | 13.92% | 8.12% | Upgrade
|
| Profit Margin | 10.31% | 10.85% | 10.26% | 10.12% | 4.71% | Upgrade
|
| Free Cash Flow Margin | -32.15% | 2.45% | 4.96% | 9.79% | 10.12% | Upgrade
|
| EBITDA | 272.83 | 271.11 | 235.39 | 206.2 | 121.22 | Upgrade
|
| EBITDA Margin | 16.25% | 17.17% | 16.61% | 16.60% | 11.07% | Upgrade
|
| D&A For EBITDA | 44 | 40.58 | 35.16 | 33.33 | 32.28 | Upgrade
|
| EBIT | 228.83 | 230.53 | 200.23 | 172.87 | 88.94 | Upgrade
|
| EBIT Margin | 13.63% | 14.60% | 14.13% | 13.92% | 8.12% | Upgrade
|
| Effective Tax Rate | 20.45% | 19.28% | 13.56% | 10.27% | 15.54% | Upgrade
|
| Revenue as Reported | 1,679 | 1,579 | 1,417 | 1,242 | 1,095 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.